No Data
No Data
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
Amarin Corp PLC (AMRN) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
Express News | Amarin Corp: In the Interim, Peter Fishman to Become Principal Financial Officer
Express News | Amarin Corp: Tom Reilly to Resign as Executive Vice President and CFO Effective October 23, 2024
Amarin Announces Two Upcoming Investor Events
Sharp Sword! The FTC sues three major pharmaceutical 'middlemen', vowing to correct the distorted chain of interests.
①The USA FTC announced on its official website that it has filed a lawsuit against three major pharmaceutical benefit managers and their affiliated organizations, accusing them of engaging in anti-competitive and unfair rebate practices; ② The FTC also "explicitly stated" in the declaration that it is deeply concerned about the roles played by Eli Lilly, Novo-Nordisk, and Sanofi, insulin pharmaceutical companies, and may suggest in future enforcement actions to prosecute these pharmaceutical manufacturers.
No Data
No Data